Skip to main navigation Skip to search Skip to main content

Relapsed or Refractory Multiple Myeloma: Early-Phase Trial Investigates Novel Bispecific Antibody

Press/Media: Press / Media

PeriodJul 27 2026

Media coverage

1

Media coverage

  • TitleRelapsed or Refractory Multiple Myeloma: Early-Phase Trial Investigates Novel Bispecific Antibody
    Media name/outletThe ASCO Post
    Country/TerritoryUnited States
    Date7/27/26
    PersonsAdam Cohen